WALTHAM, Mass., Nov. 20 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at two upcoming healthcare conferences in New York, NY.
-- Lazard Capital Markets Fourth Annual Healthcare Conference on
Wednesday, November 28, 2007 at 11:00 A.M. EST at the New York Palace
Hotel, 455 Madison Avenue, New York, NY.
-- BMO Capital Markets Focus on Healthcare Conference on Wednesday,
December 5, 2007 at 2:30 P.M. EST at the Millennium Broadway Hotel, 145
West 44th Street, New York, NY.
The live audio-webcasts of the presentations will be available via Repligen's website at http://www.repligen.com and will be archived for 90 days following the presentations.
About Repligen Corporation
Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous system. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from http://www.repligen.com.
This press release contains forward-looking statements which are made
pursuant to the safe harbor provisions of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended. The f
|SOURCE Repligen Corporation|
Copyright©2007 PR Newswire.
All rights reserved